Ralf Brinkmann

Dr. Ralf Brinkmann serves as Group Leader at the Institute for Biomedical Optics, University of Lübeck, and Managing Director of MLL GmbH. His research focuses on advancing optical imaging technologies for medical applications, particularly in neurosurgery and ophthalmology.

His primary research interests include:

• Optical Coherence Tomography (OCT) and Elastography (OCE)
• Medical imaging for brain tumor detection
• Retinal laser therapies with precise temperature control
• Laser lithotripsy and urological applications
• Development of microscope-integrated imaging systems

Dr. Brinkmann has published extensively with numerous high-impact publications from 2023-2025. His work demonstrates significant advancements in real-time temperature-controlled retinal treatments, in-situ brain tumor tissue delineation during neurosurgery, and improved laser stone ablation techniques. His research bridges engineering, physics, and clinical medicine to develop novel diagnostic and therapeutic approaches.

His publication record shows a strong focus on:

• Real-time temperature-controlled retinal laser treatments
• Brain tumor tissue delineation during neurosurgery
• Optical methods for stone ablation in urology
• Fluorescence lifetime imaging for age-related macular degeneration
• Advanced image processing for medical diagnostics

Dr. Brinkmann leads the AG Brinkmann research group and collaborates with numerous students and researchers, including Nicolas Detrez, Sazgar Burhan, Jessica Kren, and Paul Strenge, who frequently appear as co-authors on his publications. His work demonstrates strong interdisciplinary collaboration between engineering, physics, and clinical medicine, with direct applications to improving surgical outcomes and diagnostic capabilities.